Liborio Torregrossa
Overview
Explore the profile of Liborio Torregrossa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1636
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Matrone A, Citro F, Gambale C, Prete A, Minaldi E, Ciampi R, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002585
Background: Thyroid carcinoma (TC) is the most common endocrine cancer, with papillary thyroid carcinoma (PTC) being the most common subtype. BRAF and RAS oncogene were characterized as the most frequently...
12.
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients
Gambale C, Prete A, Contartese L, Torregrossa L, Bianchi F, Molinaro E, et al.
Eur Thyroid J
. 2023 Oct;
12(6).
PMID: 37855417
Background: Second 131I treatment is commonly performed in clinical practice in patients with differentiated thyroid cancer and biochemical incomplete or indeterminate response (BiR/InR) after initial treatment. Objective: The objective of...
13.
Cetani F, Pardi E, Torregrossa L, Borsari S, Pierotti L, Dinoi E, et al.
J Clin Endocrinol Metab
. 2023 Aug;
109(1):256-268.
PMID: 37531615
Parathyroid carcinoma (PC) is usually associated with severe symptomatic primary hyperparathyroidism (PHPT) and accounts for less than 1% of all cases of PHPT and approximately 0.005% of all cancers. PC...
14.
Matrone A, Gambale C, Pieroni E, De Napoli L, Torregrossa L, Materazzi G, et al.
Eur J Endocrinol
. 2023 Aug;
189(2):175-182.
PMID: 37530386
Objective: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFT-P) is an encapsulated follicular variant of papillary thyroid carcinoma (PTC) with nonaggressive clinical behavior. However, since its diagnosis is exclusively...
15.
Ramone T, Romei C, Ciampi R, Casalini R, Valetto A, Bertini V, et al.
Endocr Relat Cancer
. 2023 Jun;
30(9).
PMID: 37343157
Somatic copy number alterations (SCNA) involving either a whole chromosome or just one of the arms, or even smaller parts, have been described in about 88% of human tumors. This...
16.
Sgro D, Brancatella A, Greco G, Torregrossa L, Piaggi P, Viola N, et al.
J Clin Endocrinol Metab
. 2023 Jun;
108(11):e1186-e1192.
PMID: 37265229
Context: Prognosis is excellent for papillary thyroid carcinoma (PTC), noninvasive follicular thyroid neoplasia with papillary-like nuclear features (NIFT-P), and follicular thyroid carcinoma (FTC) but is poor for poorly differentiated thyroid...
17.
Ciampi R, Ramone T, Romei C, Casalini R, Matrone A, Prete A, et al.
Eur J Endocrinol
. 2023 May;
PMID: 37216402
Objective: 20% of sporadic MTC has no RET/RAS somatic alterations or other known gene alterations. Aim of this study was to investigate RET/RAS negative MTC for the presence of NF1...
18.
Proietti A, Signorini F, Giannini R, Poma A, Macerola E, Torregrossa L, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046812
The tall-cell variant of papillary thyroid carcinoma (TCPTC) is the most common aggressive variant of papillary thyroid carcinoma (PTC) and typically occurs in older patients. In this study, we analyzed...
19.
Rossi L, Ambrosini C, Torregrossa L, de Santi M, Guazzo R, Simoncini T, et al.
Ultrastruct Pathol
. 2023 Apr;
47(3):236-240.
PMID: 37040538
Clinical and biochemical presentation of adrenal tumors may rarely conflict with their histologic features. In the present report, we describe a rare case of adrenal neoplasm clinically and biochemically labeled...
20.
Basolo F, Macerola E, Poma A, Torregrossa L
Endocrine
. 2023 Mar;
80(3):470-476.
PMID: 36964880
The 5 edition of the World Health Organization (WHO) classification of endocrine tumors was released in 2022. Several novelties have been introduced concerning the nomenclature and histopathological diagnosis of follicular-derived...